2016, Patients, Utilities and Vaccination

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2016

Patients

Utilities

Vaccination

HPV Vaccine Secondary Acceptance: Turning No into a Yes! [Child and adolescent health]

Annals of Family Medicine

NOVEMBER 20, 2024

Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.

Vaccination

Vaccination Family Medicine DO Primary Care

Drug Pricing Reform Gathers Steam (Part 2)

FDA Law Blog

SEPTEMBER 14, 2021

Under all of these programs, patient co-insurance would be calculated based on the MFP so that patients receive the benefit of that price. For drugs approved before July 1, 2015, the baseline quarter is 1Q 2016, and for drugs approved after that date, the baseline quarter is the third full quarter after launch.

Manufacturing

Manufacturing Insurance Government Patients

Primary Care Digest

HPV Vaccine Secondary Acceptance: Turning No into a Yes! [Child and adolescent health]

Drug Pricing Reform Gathers Steam (Part 2)

Stay Connected